Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients

NCT04626960 is registered in ClinicalTrials.gov with Pamukkale University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04626960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ADRB3, ROCK2 and GEF Levels in Overactive Bladder Patients
Lead sponsor
Pamukkale University
Phase
Observational
Overall status
Completed
Start date
June 5, 2019
Completion date
June 7, 2020
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder